Correspondence 0001213900-24-011137 from BridgeBio Oncology Therapeutics, Inc. (BBOT)
BridgeBio Oncology Therapeutics, Inc.
Date: Feb. 7, 2024 · CIK: 0001869105 · Accession: 0001213900-24-011137
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-276591
Letter
February 7, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Real Estate & Construction
100 F Street, N.E.
Washington, D.C. 20549
Attention: Ronald (Ron) E. Alper
Re: Helix Acquisition Corp. II Registration Statement on Form S-1 File No. 333-276591
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), the undersigned hereby joins in the request of Helix Acquisition Corp. II that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4:00 p.m. ET on February 8, 2024, or as soon as thereafter practicable.
Pursuant to Rule 460 of the General Rules and Regulations under the Act, the undersigned wishes to advise you that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned advises that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities and Exchange Act of 1934, as amended.
[signature page follows]
Very truly yours,
Leerink Partners LLC
Show Raw Text
CORRESP
1
filename1.htm
February 7, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Real Estate & Construction
100 F Street, N.E.
Washington, D.C. 20549
Attention: Ronald (Ron) E. Alper
Re:
Helix Acquisition Corp. II
Registration Statement on Form S-1
File No. 333-276591
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act
of 1933, as amended (the “Act”), the undersigned hereby joins in the request of Helix Acquisition Corp. II that the effective
date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4:00 p.m. ET on February
8, 2024, or as soon as thereafter practicable.
Pursuant to Rule 460 of the General Rules and
Regulations under the Act, the undersigned wishes to advise you that there will be distributed to each underwriter or dealer, who is reasonably
anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears
to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned advises that it has complied and
will continue to comply with the requirements of Rule 15c2-8 under the Securities and Exchange Act of 1934, as amended.
[signature page follows]
Very truly yours,
Leerink Partners LLC
/s/ Stuart Nayman
Name:
Stuart Nayman
Title:
Managing Director, Senior Legal Counsel